RealTime eClinical Solutions has won two awards in the 2025 Clinical Trials Arena Excellence Awards for its contributions to site operations technology and brand strategy. The company received awards in both Innovation and Marketing, reflecting its recent advancements in digital platforms for clinical trial site management and its strategic rebranding initiative.
The Clinical Trials Arena Excellence Awards honor the most significant achievements and innovations in the pharmaceutical clinical trials industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies leading positive change and shaping the future of the industry.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
RealTime eClinical Solutions won the Innovation award in the Digital Platforms category for developing an integrated digital platform that streamlines site operations and enhances trial efficiency. The Marketing award was won in the Brand Innovation category for the company’s successful rebranding initiative, which unified its offerings and strengthened its presence in the clinical trials industry.
Advancing integrated digital platforms for clinical trial site operations
RealTime eClinical Solutions’ recognition in Innovation is rooted in its development and deployment of the Site Operations Management System (SOMS), which addresses longstanding challenges in clinical trial site management. Traditionally, research sites have relied on a patchwork of disconnected systems to manage critical functions such as trial management, regulatory documentation, source data capture, participant engagement, and financial transactions. This fragmentation often leads to operational inefficiencies, increased risk of errors, and difficulties in maintaining compliance across multiple studies and sponsors.
SOMS distinguishes itself by unifying these essential eClinical solutions into a single, integrated platform. For example, the Clinical Trial Management System (CTMS) within SOMS automates workflows and enhances financial oversight, while the eReg/eISF component digitizes compliance documentation, streamlining approvals and ensuring audit readiness. The eSource module enables real-time, error-free data capture, reducing protocol deviations and eliminating the need for manual transcription. Additionally, the Engage! participant portal and eConsent features facilitate direct communication with study participants, helping to reduce dropout rates and streamline the consent process.
The impact of this integration is demonstrated by significant improvements in operational metrics. Over the past year, sites using SOMS have achieved a 98% reduction in time to first participant contact and a 94% participant recruitment rate. These outcomes translate to faster study start-up times and more efficient patient recruitment, which are critical success factors in clinical research. Furthermore, the platform’s mobile app, equipped with biometric security, enables secure, compliant access to site operations on the go, supporting both single-site and multi-site research networks.
Continuous product enhancements are a hallmark of RealTime’s approach. The recent introduction of the Internal QC Portal within eSource exemplifies this commitment. This feature allows dedicated quality control users to review source data, issue internal queries, and track resolutions—all within the system and without exposing findings to external monitors. This proactive approach to data quality management not only strengthens data integrity but also accelerates study timelines by resolving issues internally before external review.
Adoption by leading sponsors and CROs, including major global pharmaceutical companies, further underscores the platform’s value. These organizations benefit from increased transparency into site operations, improved collaboration, and standardized processes across their research networks. The growing industry uptake of SOMS highlights its role in setting new standards for integrated site operations management in clinical trials.
Strengthening market presence through strategic brand innovation
RealTime’s comprehensive and well-executed rebranding initiative unified three previously distinct brands—RealTime, Devana, and Complion—under the single identity of RealTime eClinical Solutions. Prior to this transformation, the company’s market presence was fragmented, with separate websites, social media accounts, and inconsistent messaging. This fragmentation often led to customer confusion, diluted industry influence, and inefficiencies in marketing and sales outreach.
The rebranding process involved more than just visual changes; it was a strategic effort to clarify the company’s value proposition and streamline the customer journey. The new brand identity was rolled out across all digital platforms, including a refreshed website designed for improved user experience and easier navigation of the comprehensive eClinical suite. The consolidation of digital assets and messaging provided customers—whether research sites, sponsors, or CROs—with a clearer understanding of how RealTime’s solutions work together to support the entire clinical trial lifecycle, from study award and start-up to execution and analytics.
The impact of the rebrand is evident in several key outcomes. RealTime reported a 40% increase in website traffic and engagement following the launch, as well as a significant rise in marketing-sourced opportunities and enterprise-level deals. The campaign was delivered on time and under budget, demonstrating effective project management and strategic execution. Additionally, the company achieved a 100% adoption rate of the new brand across all customer touchpoints, ensuring a seamless transition for existing clients and stakeholders.
A notable element of the brand strategy was the launch of RealTime Reports, a quarterly insights series that provides data-driven analysis and benchmarking for clinical research professionals. These reports, based on targeted industry surveys, offer valuable perspectives on operational trends, compliance strategies, and financial management within the clinical trials sector. By sharing these insights, RealTime has positioned itself as a provider of industry analysis and thought leadership, further strengthening its credibility and engagement with the research community.
The rebranding initiative also improved operational efficiency within the company. Marketing and sales teams can now focus their efforts on a single, unified brand strategy, maximizing outreach and return on investment. The streamlined approach has reinforced RealTime’s authority in the eClinical space and positioned it as a comprehensive provider of integrated technology solutions for clinical research sites and networks.
“Sites are the engine of clinical research, and they deserve systems built with their real-world needs in mind. Our focus is on delivering a complete eClinical ecosystem where every part works in harmony to support better outcomes across clinical trials. Every solution we develop is designed to reduce burden, streamline workflows, and give researchers the tools they need to deliver trials with speed, quality, and confidence. We’re here to solve real problems for clinical research sites.”
– Stephen Johnson, Chief Executive Officer, RealTime eClinical Solutions
Company Profile
RealTime eClinical Solutions is a leading, enterprise-grade technology provider facilitating global clinical trials with a comprehensive eClinical platform. Purpose-built for clinical research sites, site networks, academic medical centers, sponsors, and CROs, the platform goes beyond traditional CTMS to empower research and business workflows for modern-day clinical trials.
Contact Details
E-mail: info@realtime-eclinical.com
Links
Website: https://realtime-eclinical.com/
